Fluid balance, dry weight, and blood pressure in dialysis

Hemodialysis International

Volumn 11, Issue 1, 2007, Pages 21-31

  Charra, Bernard ^a  

^a Centre de Rein Artificiel de Tassin   (France)

Author keywords

Blood pressure; Diet; Dry weight; Extracellular volume; Hemodialysis; Sodium

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; SODIUM;

ACCURACY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DIALYSATE; DISEASE CONTROL; DRY WEIGHT; EXTRACELLULAR SPACE; FLUID BALANCE; HEMODIALYSIS; HUMAN; HYPERTENSION; IMPEDANCE; NATRIURESIS; SODIUM BALANCE; SODIUM RESTRICTION; SODIUM TRANSPORT; ULTRAFILTRATION;

BLOOD PRESSURE; FLUID THERAPY; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 33846345848     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00148.x     Document Type: Article

References (67)

1. Luft FC, Weinberger MH, Grim CE. Sodium sensitivity and resistance in normotensive humans. Am J Med. 1982; 72: 726-736.
2. Guyton AC. Kidneys and fluids in pressure regulation: Small volume but large pressure changes. Hypertension. 1992; 19(Suppl 1):12-18.
3. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a "no-salt" culture. Circulation. 1975; 52: 146.
4. Brenner BM. Retarding the progression of renal disease. Kidney Int. 2003; 64: 370-378.
5. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001; 345: 851-860.
6. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Arch Intern Med. 2001; 135: 73-87.
7. Koomans HA, Roos JC, Boer P, Greyskes GG, Dorhout Mees EJ. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension. 1982; 4: 190-197.
8. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334: 13-18.
9. Acosta JH. Hypertension in chronic renal disease. Kidney Int. 1982; 22: 702-712.
10. Vertes V, Cangiano JL, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med. 1969; 280: 978-981.
11. Guyton AC. Arterial Pressure and Hypertension. London: W.B. Saunders Company; 1980.
12. Coleman TG, Granger GJ, Guyton AC. Whole-body circulatory autoregulation and hypertension. Circ Res. 1971; 5(Suppl 2):76-87.
13. Kim KE, Onesti G, Swartz C. Hemodynamics of hypertension in chronic end-stage renal disease. Circulation. 1972; 46: 456-461.
14. Koomans HA, Geers AB, Boer P, Roos JC, Dorhout Mees EJ. A study on distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: Preferential intravascular deposition in renal failure. Clin Sci. 1983; 64: 153-160.
15. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int. 1981; 20: 246-253.
16. Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992; 327: 1912-1918.
17. Ritz E, Koomans HA. New insights into mechanisms of blood pressure regulation in patients with uremia. Nephrol Dial Transplant. 1996; 11(Suppl 2):52-59.
18. Weidmann P, Beretta-Piccoli C, Steffin F, Blumberg A, Reubi FC. Hypertension in terminal renal failure. Kidney Int. 1976; 9: 294.
19. Imai Y, Abe K, Otsuka Y, et al. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure. Jpn Circ J. 1981; 45: 303-314.
20. Matsuoka H, Kimura G, Sanai T, et al. Normalization of increased sodium sensitivity in maintenance hemodialysis. Am J Hypertension. 1990; 3: 628-631.
21. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. J Am Soc Nephrol. 1999; 10: 2248-2258.
22. Schmieder RE. Dietary intake and left ventricular hypertrophy. Nephrol Dial Transplant. 1997; 12: 145-248.
23. Titze J, Krauze H, Hecht H, et al. Reduced osmotically inactive sodium storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol. 2002; 283: F134-141.
24. Kitiyakara C, Chabrashvili T, Chen Y, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol. 2003; 14: 2775-2782.
25. Scribner BH, Buri R, Caner JEZ, Hegstrom RM, Burnell JM. The treatment of chronic uremia by the means of intermittent dialysis: A preliminary report. Trans Am Soc Artific Intern Organs. 1960; 6: 114-119.
26. Comty C, Rottka H, Shaldon S. Blood pressure control in patients with end-stage renal failure treated by intermittent dialysis. Proc Eur Dial Transplant Assoc. 1964; 1: 209-214.
27. Comty C, Baillod RM, Crockett R, Shaldon S. Forty months experience with a nurse-patient operated chronic dialysis unit. Proc Eur Dial Transplant Assoc. 1966; 3: 98-101.
28. Blumberg A, Nelp WD, Hegstrom RM, Scribner BH. Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet. 1967; 2: 69-73.
29. Thomson GE, Waterhouse K, Mc Donald HPJ, Friedman EA. Hemodialysis for chronic renal failure. Arch Intern Med. 1967; 120: 153-167.
30. Schupak E, Sullivan JF, Lee DY. Chronic hemodialysis in "unselected" patients. Ann Intern Med. 1967; 67: 708-717.
31. de Planque BA, Mulder E, Dorhout Mees EJ. The behavior of blood and extracellular volume in hypertensive patients with renal insufficiency. Acta Medica Scandinavia. 1969; 186: 75-81.
32. Curtis JR, Eastwood JB, Smith EKM, et al. Maintenance Haemodialysis. Q J Med. 1969; 37: 49-89.
33. Traeger J, Zech P, Francois B, et al. Arterial hypertension in chronic kidney failure treated by extra-renal dialysis. Aquisitions Méd Récentes. 1969; 261-296.
34. Sellars L, Robson V, Wilkinson R. Sodium retention and hypertension with short dialysis. Br Med J. 1979; 1: 520-521.
35. Charra B, Chazot C, Laurent G, et al. Clinical assessment of dry weight. Nephrol Dial Transplant. 1996; 11(Suppl 2):16-19.
36. Goldsmith DJA, Covic AA, Venning MC, Ackrill P. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis. 1997; 29: 593-600.
37. Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE. Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int. 2002; 62: 2281-2287.
38. Charra B. Control of blood pressure in long slow hemodialysis. Blood Purif. 1994; 12: 252-258.
39. Katzarski KS, Charra B, Luik A, et al. Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant. 1999; 14: 369-375.
40. Luik AJ, Charra B, Katzarski KS, et al. Blood pressure control and fluid state in patients on long treatment time dialysis (abstract). J Am Soc Nephrol. 1994; 5: 521.
41. Özkahya M, Töz H, Ünsal A, et al. Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis. 1999; 34: 218-221.
42. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994; 330: 1431-1438.
43. Khosla UM, Johnson RJ. Hypertension in the hemodialysis patient and the "lag phenomenon": Insight into physiopathology and clinical management. Am J Kidney Dis. 2004; 43: 739-751.
44. Wizemann V, Schilling M. Dilemna of assessing volume state- the use and the limitations of a clinical score. Nephrol Dial Transplant. 1995; 10: 2114-2117.
45. Chazot C, Charra B, Vo Van C, et al. The Janus-faced aspect of "dry weight." Nephrol Dial Transplant. 1999; 14: 121-124.
46. Charra B, Bergström J, Scribner BH. Blood Pressure control in dialysis patients. The importance of the lag phenomenon. Am J Kid Dis. 1998; 32: 720-724.
47. Hegström RM, Murray JS, Pendras JP, Burnell JM, Scribner BH. Hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs. 1961; 7: 136-152.
48. Scribner BH. Can antihypertensive medications control BP in haemodialysis patients: Yes or no? Nephrol Dial Transplant. 1999; 14: 2599-2601.
49. Zhu F, Schneditz D, Levin NW. Sum of segmental bioimpedance analysis during ultrafiltration and hemodialysis reduces sensitivity to changes in body position. Kidney Int. 1999; 56: 692-699.
50. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis. The RXc graph. Kidney Int. 1994; 46: 534-539.
51. Chamney PW, Kramer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. 2002; 61: 2250-2258.
52. Zhu F, Kuhlmann MK, Sarkar S, et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int of Artif Organs. 27: 104-109.
53. Franz M, Pohanka E, Tribl B, Woloszczuk W, Hörl WH. Living on chronic hemodialysis between dryness and fluid overload. Kidney Int. 1997; 51(Suppl 59):S39-S42.
54. Iseki I, Miyasato F, Tokuyama K, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997; 51: 1212-1217.
55. Salem MM, Bower JD. Hypertension in the hemodialysis population: Any relation to the one-year survival? Am J Kidney D. 1996; 28: 737-740.
56. Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodiaysis patients. Am J Kidney Dis. 1999; 33: 507-517.
57. Zager P, Campbell M, Skipper B, et al. Effect of blood pressure on mortality in hemodialysis patients (abstract). J Am Soc Nephrol. 1994; 5: 534.
58. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006.
59. Wizemann V, Mueller K, Kramer W, Schütterle G. Ten years experience with short dialysis: A decade of cardiovascular complications (abstract). Nephrol Dial Transplant. 1986; 1: 100.
60. Krautzig S, Janssen U, Koch KM, Granoleras C, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant. 1998; 13: 552-553.
61. Scribner BH. A personalized history of chronic hemodialysis. Am J Kidney Dis. 1990; 6: 511-519.
62. Zucchelli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol. 1988; 8: 163.
63. Mailloux LU, Haley WE. Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis. 1998; 32: 705-719.
64. Hörl MP, Hörl WH. Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis. 2002; 39: 227-244.
65. Günal AI, Duman S, Ozkahya M, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001; 37: 588-593.
66. Lameire N, van Biesen W. Importance of blood pressure and volume control in peritoneal dialysis patients. Peritoneal Dial Int. 2001; 21: 206-211.
67. Mann H, Stiller S. Sodium modeling. Kidney Int. 2000; 58(Suppl 76):S79-S88.